Biocoat Launches Coating Equipment Business Unit; Completes Full-Service Hydrophilic Coating Offering

Biocoat Inc. announced its expansion into the design, development and delivery of hydrophilic dip coating equipment.  Biocoat’s new equipment line is called EMERSE and offers companies who require an in-house dip coating system to coat their medical devices and complete the production process.

The addition of coating equipment now positions Biocoat as one of the only companies that can offer a complete, full-service solution for medical devices that require a hydrophilic coating. The EMERSE hydrophilic dip coating system is specifically designed and manufactured to meet the rigorous requirements that are encountered when coating products in the medical device, pharmaceutical, biotechnology and life science industries. Biocoat’s coating systems will be available in either Thermal heat or Ultraviolet (UV) cure systems and is available in two models, the semi-automated Compact system, that offers an annual production of ~25,000 units per year per shift and the One Touch automated system that can coat ~75,000-100,000 units per year per shift.

“The addition of coating equipment fulfills our strategic vision of making Biocoat the premier full-service coatings company to partner with for medical device companies.” said Jim Moran, President, and CEO, Biocoat. “Our coating systems will be automated and fully compatible for use on either our industry leading HYDAK® coatings or any other coatings in the market. Our aim is to work closely with our customers to provide the highest level of service available, while ensuring that we deliver the equipment on-time and on-budget, every time.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version